WHO ICTRP trial
A single-center, open-label study to evaluate the absorption, distribution…
NL-OMON46062 · Overview of Medical Research in the Netherlands (NL-OMON) · Not Recruiting
Key facts
| Trial ID | NL-OMON46062 |
|---|---|
| Public title | A single-center, open-label study to evaluate the absorption, distribution, metabolism and excretion (ADME) and pharmacokinetics of QBW251 following a single oral dose of [14C]QBW251 in healthy male subjects at steady state conditions. |
| Scientific title | A single-center, open-label study to evaluate the absorption, distribution, metabolism and excretion (ADME) and pharmacokinetics of QBW251 following a single oral dose of [14C]QBW251 in healthy male subjects at steady state conditions. - QBW251 human ADME study at steady state in healthy male… |
| Primary sponsor | Novartis Pharma AG |
| Registry | Overview of Medical Research in the Netherlands (NL-OMON) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Countries | The Netherlands |
| Conditions | Longaandoeningen COPD lung diseases;COPD;lung diseases |
| Interventions | Not applicable. ;ADME;COPD;QBW251 |
| Registration date | Oct 24, 2018 |
| Target size | 6 |
| Secondary IDs | 2018-001841-15;NL67518.056.18 |
| Registry page | onderzoekmetmensen.nl |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: